Autologous dendritic cells prolong allograft survival through Tmem176b-dependent antigen cross-presentation

American Journal of Transplantation

Volumn 14, Issue 5, 2014, Pages 1021-1031

  Segovia, M ^a,f   Louvet, C ^a   Charnet, P ^b   Savina, A ^c,d   Tilly, G ^a   Gautreau, L ^a   Carretero Iglesia, L ^a   Beriou, G ^a   Cebrian, I ^c,d   Cens, T ^b   Hepburn, L ^e   Chiffoleau, E ^a   Floto, R A ^e   Anegon, I ^a   Amigorena, S ^c,d   Hill, M ^a,f   Cuturi, M C ^a  

^a Centre National de la Recherche Scientifique   (France)

^b Centre National de la Recherche Scientifique   (France)

^c INSTITUT CURIE   (France)

^d PSL RESEARCH UNIVERSITY   (France)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

Author keywords

Autologous dendritic cells; cellular therapy; cross presentation; ion channel

Indexed keywords

CD3 ANTIBODY; GLYCOPROTEIN P 15095; MEMBRANE PROTEIN; OVALBUMIN; TMEM176B PROTEIN; UNCLASSIFIED DRUG; CD3 ANTIGEN; MONOCLONAL ANTIBODY; TMEM176B PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; AUTOLOGOUS TOLEROGENIC DENDRITIC CELL; CD8+ T LYMPHOCYTE; CELL MATURATION; CELL THERAPY; CONTROLLED STUDY; CROSS PRESENTATION; DENDRITIC CELL; FEMALE; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MALE; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SKIN TRANSPLANTATION; ALLOGRAFT; ANIMAL; ANTIGEN PRESENTATION; C57BL MOUSE; ELECTROPHYSIOLOGY; ENDOCYTOSIS; FLOW CYTOMETRY; IMMUNOLOGY; KNOCKOUT MOUSE; PHAGOCYTOSIS; PHYSIOLOGY;

ALLOGRAFTS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; ANTIGENS, CD3; CD8-POSITIVE T-LYMPHOCYTES; CROSS-PRIMING; DENDRITIC CELLS; ELECTROPHYSIOLOGY; ENDOCYTOSIS; FEMALE; FLOW CYTOMETRY; GRAFT SURVIVAL; IMMUNE TOLERANCE; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHAGOCYTOSIS; SKIN TRANSPLANTATION;

EID: 84898934365     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12708     Document Type: Article

References (51)

1. Bluestone JA, Thomson AW, Shevach EM, Weiner HL., What does the future hold for cell-based tolerogenic therapy ? Nat Rev Immunol 2007; 7: 650-654.
2. Morelli AE, Thomson AW., Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 2007; 7: 610-621.
3. Beriou G, Peche H, Guillonneau C, Merieau E, Cuturi MC., Donor-specific allograft tolerance by administration of recipient-derived immature dendritic cells and suboptimal immunosuppression. Transplantation 2005; 79: 969-972.
4. Peche H, Trinite B, Martinet B, Cuturi MC., Prolongation of heart allograft survival by immature dendritic cells generated from recipient type bone marrow progenitors. Am J Transplant 2005; 5: 255-267.
5. Moreau A, Hill M, Thebault P, et al. Tolerogenic dendritic cells actively inhibit T cells through heme oxygenase-1 in rodents and in nonhuman primates. FASEB J 2009; 23: 3070-3077.
6. Segovia M, Cuturi MC, Hill M., Preparation of mouse bone marrow-derived dendritic cells with immunoregulatory properties. Methods Mol Biol 2011; 677: 161-168.
7. Hill M, Cuturi MC., Negative vaccination by tolerogenic dendritic cells in organ transplantation. Curr Opin Organ Transplant 2010; 15: 738-743.
8. Hill M, Thebault P, Segovia M, et al. Cell therapy with autologous tolerogenic dendritic cells induces allograft tolerance through interferon-gamma and Epstein-Barr virus-induced gene 3. Am J Transplant 2011; 11: 2036-2045.
9. Beriou G, Moreau A, Cuturi MC., Tolerogenic dendritic cells: Applications for solid organ transplantation. Curr Opin Organ Transplant 2012; 17: 42-47.
10. Giannoukakis N, Phillips B, Finegold D, Harnaha J, Trucco M., Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients. Diabetes Care 2011; 34: 2026-2032.
11. Moreau A, Varey E, Beriou G, et al. Tolerogenic dendritic cells and negative vaccination in transplantation: From rodents to clinical trials. Front Immunol 2012; 3: 218.
12. Louvet C, Chiffoleau E, Heslan M, et al. Identification of a new member of the CD20/FcepsilonRIbeta family overexpressed in tolerated allografts. Am J Transplant 2005; 5: 2143-2153.
13. Condamine T, Le Texier L, Howie D, et al. Tmem176B and Tmem176A are associated with the immature state of dendritic cells. J Leukoc Biol 2010; 88: 507-515.
14. Savina A, Jancic C, Hugues S, et al. NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell 2006; 126: 205-218.
15. Jancic C, Savina A, Wasmeier C, et al. Rab27a regulates phagosomal pH and NADPH oxidase recruitment to dendritic cell phagosomes. Nat Cell Biol 2007; 9: 367-378.
16. Mantegazza AR, Savina A, Vermeulen M, et al. NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells. Blood 2008; 112: 4712-4722.
17. Joffre OP, Segura E, Savina A, Amigorena S., Cross-presentation by dendritic cells. Nat Rev Immunol 2012; 12: 557-569.
18. Savina A, Peres A, Cebrian I, et al. The small GTPase Rac2 controls phagosomal alkalinization and antigen crosspresentation selectively in CD8(+) dendritic cells. Immunity 2009; 30: 544-555.
19. Savina A, Amigorena S., Phagocytosis and antigen presentation in dendritic cells. Immunol Rev 2007; 219: 143-156.
20. Amigorena S, Savina A., Intracellular mechanisms of antigen cross presentation in dendritic cells. Curr Opin Immunol 2010; 22: 109-117.
21. De Wilde V, Van Rompaey N, Hill M, et al. Endotoxin-induced myeloid-derived suppressor cells inhibit alloimmune responses via heme oxygenase-1. Am J Transplant 2009; 9: 2034-2047.
22. James E, Scott D, Chai JG, Millrain M, Chandler P, Simpson E., HY peptides modulate transplantation responses to skin allografts. Int Immunol 2002; 14: 1333-1342.
23. Bienvenu B, Martin B, Auffray C, Cordier C, Becourt C, Lucas B., Peripheral CD8+CD25+ T lymphocytes from MHC class II-deficient mice exhibit regulatory activity. J Immunol 2005; 175: 246-253.
24. Najafian N, Chitnis T, Salama AD, et al. Regulatory functions of CD8+CD28- T cells in an autoimmune disease model. J Clin Invest 2003; 112: 1037-1048.
25. Seo SK, Choi JH, Kim YH, et al. 4-1BB-mediated immunotherapy of rheumatoid arthritis. Nat Med 2004; 10: 1088-1094.
26. Shui W, Sheu L, Liu J, et al. Membrane proteomics of phagosomes suggests a connection to autophagy. Proc Natl Acad Sci USA 2008; 105: 16952-16957.
27. Trost M, English L, Lemieux S, Courcelles M, Desjardins M, Thibault P., The phagosomal proteome in interferon-gamma-activated macrophages. Immunity 2009; 30: 143-154.
28. Accapezzato D, Visco V, Francavilla V, et al. Chloroquine enhances human CD8+ T cell responses against soluble antigens in vivo. J Exp Med 2005; 202: 817-828.
29. Maeda Y, Fujimura L, O-Wang J, et al. Role of Clast1 in development of cerebellar granule cells. Brain Res 2006; 1104: 18-26.
30. Pfeufer A, Sanna S, Arking DE, et al. Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Nat Genet 2009; 41: 407-414.
31. Zuccolo J, Bau J, Childs SJ, Goss GG, Sensen CW, Deans JP., Phylogenetic analysis of the MS4A and TMEM176 gene families. PLoS ONE 2010; 5: e9369.
32. Lan JY, Skeberdis VA, Jover T, et al. Protein kinase C modulates NMDA receptor trafficking and gating. Nat Neurosci 2001; 4: 382-390.
33. Lutz MB, Suri RM, Niimi M, et al. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol 2000; 30: 1813-1822.
34. Divito SJ, Wang Z, Shufesky WJ, et al. Endogenous dendritic cells mediate the effects of intravenously injected therapeutic immunosuppressive dendritic cells in transplantation. Blood 2010; 116: 2694-2705.
35. Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, Bhardwaj N., Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 2001; 193: 233-238.
36. Dhodapkar MV, Steinman RM., Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans. Blood 2002; 100: 174-177.
37. Segura E, Touzot M, Bohineust A, et al. Human inflammatory dendritic cells induce Th17 cell differentiation. Immunity 2013; 38: 336-348.
38. You S, Chatenoud L., New generation CD3 monoclonal antibodies: Are we ready to have them back in clinical transplantation ? Curr Opin Organ Transplant 2010; 15: 720-724.
39. Perruche S, Zhang P, Liu Y, Saas P, Bluestone JA, Chen W., CD3-specific antibody-induced immune tolerance involves transforming growth factor-beta from phagocytes digesting apoptotic T cells. Nat Med 2008; 14: 528-535.
40. Bisikirska B, Colgan J, Luban J, Bluestone JA, Herold KC., TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs. J Clin Invest 2005; 115: 2904-2913.
41. Lee YR, Yang IH, Lee YH, et al. Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells. Blood 2005; 105: 3951-3955.
42. Albert ML, Jegathesan M, Darnell RB., Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nat Immunol 2001; 2: 1010-1017.
43. Li XL, Menoret S, Bezie S, et al. Mechanism and localization of CD8 regulatory T cells in a heart transplant model of tolerance. J Immunol 2010; 185: 823-833.
44. Fuchs R, Male P, Mellman I., Acidification and ion permeabilities of highly purified rat liver endosomes. J Biol Chem 1989; 264: 2212-2220.
45. Lukacs GL, Rotstein OD, Grinstein S., Determinants of the phagosomal pH in macrophages. In situ assessment of vacuolar H(+)-ATPase activity, counterion conductance, and H+ "leak ". J Biol Chem 1991; 266: 24540-24548.
46. Steinberg BE, Touret N, Vargas-Caballero M, Grinstein S., In situ measurement of the electrical potential across the phagosomal membrane using FRET and its contribution to the proton-motive force. Proc Natl Acad Sci USA 2007; 104: 9523-9528.
47. Casey JR, Grinstein S, Orlowski J., Sensors and regulators of intracellular pH. Nat Rev Mol Cell Biol 2010; 11: 50-61.
48. Barbet G, Demion M, Moura IC, et al. The calcium-activated nonselective cation channel TRPM4 is essential for the migration but not the maturation of dendritic cells. Nat Immunol 2008; 9: 1148-1156.
49. Mariathasan S, Weiss DS, Newton K, et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006; 440: 228-232.
50. Compan V, Baroja-Mazo A, Lopez-Castejon G, et al. Cell volume regulation modulates NLRP3 inflammasome activation. Immunity 2012; 37: 487-500.
51. Latz E, Xiao TS, Stutz A., Activation and regulation of the inflammasomes. Nat Rev Immunol 2013; 13: 397-411.